Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-10
DOI
10.3389/fneur.2017.00577
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacodynamic effects of daclizumab in the intrathecal compartment
- (2017) Mika Komori et al. Annals of Clinical and Translational Neurology
- Sustained reduction of MS disability
- (2016) Bibiana Bielekova et al. NEUROLOGY
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
- (2015) Mika Komori et al. ANNALS OF NEUROLOGY
- Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method
- (2015) Runze Yang et al. Scientific Reports
- A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis
- (2014) Simone C. Wuest et al. PLoS One
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
- (2013) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
- (2012) Marie T. Fischer et al. BRAIN
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
- (2012) Virginia Devonshire et al. LANCET NEUROLOGY
- Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis
- (2012) Aaron E Miller et al. Multiple Sclerosis Journal
- Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis
- (2012) JM McMahon et al. Multiple Sclerosis Journal
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- The (mis)use of overlap of confidence intervals to assess effect modification
- (2011) Mirjam J. Knol et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
- (2010) Graham R. Campbell et al. ANNALS OF NEUROLOGY
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- “Tissue-repairing” blood-derived macrophages are essential for healing of the injured spinal cord: From skin-activated macrophages to infiltrating blood-derived cells?
- (2010) Michal Schwartz BRAIN BEHAVIOR AND IMMUNITY
- Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach
- (2009) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
- (2009) M. Hutchinson et al. JOURNAL OF NEUROLOGY
- Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
- (2009) Bruce D Trapp et al. LANCET NEUROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started